Previous Page  26 / 38 Next Page
Information
Show Menu
Previous Page 26 / 38 Next Page
Page Background

Tivozanib vs Sorafenib:

favorable tolerability

14% dose reductions

&

4% discontinuations

1 … 21 22 23 24 25 26 27 28 29 30 31 32 … 38